• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

ASCO

Pharma

ASCO: Will Seagen's Adcetris be a growing force in lymphoma?

At ASCO, Seagen and Takeda presented trial data that show Adcetris could become at growing force in the treatment of various forms of lymphoma.
Kevin Dunleavy May 26, 2022 5:00pm

Bayer hikes Nubeqa's peak sales to over €3B amid 3-way battle

Feb 17, 2022 4:32pm

Zejula gives J&J mixed success in prostate cancer

Feb 14, 2022 5:00pm

Is pharma ready to talk cure in cancer? AZ convenes panel debate

Jun 1, 2021 11:28am

Exelixis highlights the Cabometyx thyroid cancer phase 3 data

May 19, 2021 5:01pm

Is Keytruda-Lenvima the winner in kidney cancer?

Feb 17, 2021 4:08pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy